IPAMORELIN 2000mcg

Ipamorelin is a synthetic pentapeptide studied in vitro for its interaction with the growth hormone secretagogue receptor (GHS-R), the same receptor activated by the endogenous hormone ghrelin.

This product is studied in cell-based laboratory research and is not intended for human consumption.

Peptide Structure and the Aib Substitution

Ipamorelin's N-terminal residue is Aib (2-aminoisobutyric acid), a non-proteinogenic amino acid rather than a standard L-amino acid. This substitution is of structural interest because Aib's quaternary carbon prevents the standard peptide backbone rotation available to natural amino acids, constraining the peptide's conformation.

Researchers studying secretagogue peptide design have also noted that Aib and other non-standard residues are generally poor substrates for exopeptidases, a structural property relevant to a peptide's resistance to enzymatic degradation in laboratory assay systems.

Receptor-Binding Assay Design in Cell-Based Systems

Laboratory research on GHS-R-targeting peptides commonly relies on cell lines engineered to express the receptor of interest, allowing researchers to measure ligand binding and downstream signaling within a controlled cell culture system.

This approach isolates a single receptor's response from the many other signaling pathways present in a whole organism, and is a standard methodology for characterizing GHS-R ligands at the cellular level.

Comparative Structural Context Among GH Secretagogues

Ipamorelin shares a related design lineage with other GHS-R-targeting research peptides, including GHRP-2 and GHRP-6, all of which retain a D-2-naphthylalanine, D-tryptophan, or similar bulky aromatic D-amino acid combined with a D-phenylalanine and C-terminal lysinamide.

Researchers comparing these structurally related peptides have focused on how substitutions at just one or two positions in an otherwise conserved short sequence can meaningfully alter receptor engagement, a recurring theme in structure-activity research on this peptide class.

Analytical Purity Verification

Purity assessment for research peptides such as this one typically relies on a combination of high-performance liquid chromatography (HPLC) and mass spectrometry, confirming both the identity of the synthesized sequence and the absence of truncated or deamidated byproducts that can arise during synthesis.

A certificate of analysis reporting purity above 99% by these combined methods is generally regarded in laboratory settings as an indicator of suitability for reproducible in vitro experimental work.

Storage and Handling in the Laboratory Setting

Lyophilized peptide is generally more stable in its freeze-dried state, which is why laboratories typically store material under sub-zero freezer conditions and limit exposure to light and room temperature, since thermal cycling of the storage environment can compromise the reliability of downstream in vitro assay data.

Important Notice

Ipamorelin is intended exclusively for laboratory research use (in vitro) and is not for human consumption. This product has not been evaluated for safety or efficacy in humans, and these findings do not establish safety or efficacy for any human application.

Product Information

Ipamorelin is available as a lyophilized white powder in a 2000 mcg vial.